OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of the Neurological Sciences is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Brain health as a global priority, view from WHO: Editorial from the World Federation of Neurology	549
Retraction notice to “Risk factors for hip fracture among elderly patients with Parkinson's disease” [Journal of the Neurological Sciences 182 (2001), 89–93]	185
Myasthenia gravis patients exhibiting an eyelid myotonia-like phenomenon	165
Diagnosing progressive multifocal leukoencephalopathy: Positive predictive value of CSF JC virus quantitative PCR and importance of recognizing suggestive neuroimaging findings	70
Multiple sclerosis twin study reveals distinct genetic, disease-specific, and psychometric impact on coping with critical life events	67
White matter hyperintensities in patients with Parkinson's disease: A systematic review and meta-analysis	55
The interplay between structural and functional connectivity in early stage Parkinson's disease patients	54
Elevated cerebrospinal fluid neuronal injury biomarkers within 24 hours of onset in infection-triggered acute encephalopathy compared to complex febrile seizures	46
Addressing the barrier of transport costs in accessing headache care in Sub-Saharan Africa	45
Pathomechanism of infantile traumatic brain injury with a biphasic clinical course and late reduced diffusion evaluated by MR spectroscopy	41
HTRA1-related cerebral small-vessel disease causes cerebral microbleeds on the brainstem surface	40
Response to Aanwat et al. on chow et al. Tricaprilin (CER-0001) for the preventive treatment of migraine: A phase 2 randomised, double-blind, placebo-controlled pilot study JONS July 22, 2024	40
Acute stroke care inequities: Cross-cultural insights and the need for multi-ethnic research	37
Corrigendum to “Hemorrhagic shock and encephalopathy syndrome: A call for new clinical criteria for early intervention” [Journal of the Neurological Sciences, 465 (2024) in press (JNS 123207)]	37
Efficacy of a mitochondrial drug cocktail in preventing acute encephalopathy with biphasic seizures and late reduced diffusion	36
The reliability and validity of in-person and remote behavioural screening tools for people with amyotrophic lateral sclerosis	36
Characteristics and prognostic impact of unsuccessful recanalization after endovascular therapy for acute ischemic stroke	35
Perampanel for the treatment of Asian people with epilepsy: Real-world evidence from the PERMIT extension study	35
Laboratory evaluation for the differential diagnosis of possible multiple sclerosis in the United States: A physician survey	34
CD8 T cell-mediated cerebellitis directed against Purkinje cell antigen after ipilimumab for small cell lung cancer	33
Transforming healthcare: User-friendly digital health technologies in the era of Society 5.0	33
CSF 14–3-3 zeta(ζ) isoform is associated with tau pathology and cognitive decline in Alzheimer's disease	32
Clinical, radiological, and molecular analyses of neuronal intranuclear inclusion disease with polyglycine inclusions	32
Essential tremor: Clinical perspectives and pathophysiology	32
Continuing the search for fluid biomarkers to enhance Huntington's disease staging and therapeutic response	31

Cerebrospinal fluid glial fibrillary acidic protein, in contrast to amyloid beta protein, is associated with disease symptoms in Huntington's disease	31
Retraction notice to “Reply to Davie and Sharp: Different mechanisms of bone metabolism between patients with stroke and with spinal cord injury” [Journal of the Neurological Sciences 163 (1999) 100–1	30
Overcoming barriers in Global Neurological Care: A call for innovation and policy change by Ishan MZ et al: Response to Ishan MZ et al and an appreciation of the potential value of the World Federatio	30
Editorial Board	30
Effects of safinamide adjunct therapy on pain in patients with Parkinson's disease: Post hoc analysis of a Japanese phase 2/3 study	29
A spectrum of neurological diseases with elevated cerebrospinal fluid adenosine deaminase levels	29
Clinical analysis of complications of cavernous sinus thrombosis in COVID-19 patients	29
Concomitant high oxidative stress and poor antioxidant enzyme activity with DNA damage may underlie obesity and reduced longevity in WNIN/Ob obese rats	29
Degeneration of nigrostriatal dopaminergic neurons in the early to intermediate stage of dementia with Lewy bodies and Parkinson's disease	29